Retinal Vein Occlusions Bibliography

Branch Vein Occlusion Study Group. Argon laser photocoagulation for macular edema in branch vein occlusion. Am J Ophthalmol. 1984;98(3):271-282. doi:10.1016/0002-9394(84)90316-7.

Branch Vein Occlusion Study Group. Argon laser scatter photocoagulation for prevention of neovascularization and vitreous hemorrhage in branch vein occlusion: a randomized clinical trial. Arch Ophthalmol. 1986;104(1):34-41. doi:10.1001/archopht.1986.01050130044017.

Brown DM, Campochiaro PA, Singh RP, et al; CRUISE Investigators. Ranibizumab for macular edema following central retinal vein occlusion: six-month primary end point results of a phase III study [published online April 9, 2010]. Ophthalmology. 2010;117(6):1124–1133. doi:10.1016/j.ophtha.2010.02.022.

Brown DM, Heier JS, Clark WL, et al. Intravitreal aflibercept injection for macular edema secondary to central retinal vein occlusion: 1-year results from the phase 3 COPERNICUS Study [published online December 4, 2012]. Am J Ophthalmol. 2013;155(3):429–437. doi:10.1016/j.ajo.2012.09.026.

Campochiaro PA, Brown DM, Awh CC, et al. Sustained benefits from ranibizumab for macular edema following central retinal vein occlusion: twelve-month outcomes of a phase III study [published online June 29, 2011]. Ophthalmology. 2011;118(10):2041–2049. doi:10.1016/j.ophtha.2010.02.021.

Campochiaro PA, Clark WL, Boyer DS, et al. Intravitreal aflibercept for macular edema following branch retinal vein occlusion: the 24-week results of the VIBRANT Study [published online October 11, 2014]. Ophthalmology. 2015;122(3):538-544. doi:10.1016/j.ophtha.2014.08.031.

Campochiaro PA, Heier JS, Feiner L, et al; BRAVO Investigators. Ranibizumab for macular edema following branch retinal vein occlusion: six-month primary end point results of a phase III study [published online April 15, 2010]. Ophthalmology. 2010;117(6):1102–1112. doi:10.1016/j.ophtha.2010.02.021.

Capone A Jr, Singer MA, Dodwell DG, et al. Efficacy and safety of two or more dexamethasone intravitreal implant injections for treatment of macular edema related to retinal vein occlusion (SHASTA Study). Retina. 2014;34(2):342-351. doi:10.1097/IAE.0b013e318297f842.[ES1] 

Central Vein Occlusion Study Group. A randomized clinical trial of early panretinal photocoagulation for ischemic central vein occlusion: the Central Vein Occlusion Study Group N report. Ophthalmology. 1995;102(10):1434-1444. doi:10.1016/S0161-6420(95)30848-2.

Central Vein Occlusion Study Group. Natural history and clinical management of central retinal vein occlusion. Arch Ophthalmol. 1997;115(4):486-491. doi:10.1001/archopht.1997.01100150488006.

Haller, JA, Bandello F, Belfort R Jr, et al; OZURDEX GENEVA Study Group. Randomized, sham-controlled trial of dexamethasone intravitreal implant in patients with macular edema due to retinal vein occlusion [published online April 24, 2010]. Ophthalmology. 2010;117(6):1134-1146.e3. doi:10.1016/j.ophtha.2010.03.032.

Heier JS, Clark WL, Boyer DS, et al. Intravitreal aflibercept injection for macular edema due to central vein occlusion: two-year results from the COPERNICUS Study [published online March 27, 2014]. Ophthalmology. 2014;121(7):1414-1420. doi:10.1016/j.ophtha.2014.01.027. 

Ip MS, Scott IU, VanVeldhuisen PC, et al; SCORE Study Research Group. A randomized trial comparing the efficacy and safety of intravitreal triamcinolone with observation to treat vision loss associated with macular edema secondary to central retinal vein occlusion: the Standard Care vs Corticosteroid for Retinal Vein Occlusion (SCORE) Study report 5. Arch Ophthalmol. 2009;127(9):1101-1114. doi:10.1001/archophthalmol.2009.234.

Korobelnik JF, Holz FG, Roider J, et al; GALILEO Study Group. Intravitreal aflibercept injection for macular edema resulting from central retinal vein occlusion: one-year results of the Phase 3 GALILEO Study [published online September 29, 2013]. Ophthalmology. 2014;121(1):202-208. doi:10.1016/j.ophtha.2013.08.012.

Scott IU, Ip MS, VanVeldhuisen PC, et al; SCORE Study Research Group. A randomized trial comparing the efficacy and safety of intravitreal triamcinolone with standard care to treat vision loss associated with macular edema secondary to branch retinal vein occlusion: the Standard Care vs Corticosteroid for Retinal Vein Occlusion (SCORE) Study report 6. Arch Ophthalmol. 2009;127(9):1115-1128. doi:10.1016/j.ophtha.2010.02.022.


Updated February 2018